Clinical Trial Update: Hepatic Impairment With Cirrhosis Due to Cholestatic Liver Disease [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update indicating a study evaluating hepatic impairment with cirrhosis due to cholestatic liver disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholestatic Liver Disease
• Cirrhosis

Snippet

Sponsor: Zydus Therapeutics Inc. | Conditions: Hepatic Impairment, Cirrhosis | Phase 1 | Status: RECRUITING